ArticleCureus2022
An Extremely Rare Nasopharyngeal Malignant Tumor: A Case Report.
Article in Cureus, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.
- Radiological features of thyroid-like low-grade nasopharyngeal papillary adenocarcinoma: case series and systematic review.Neuroradiology · 2024Pooled it
- A Rare Case of a Large Sinonasal Neurofibroma.Cureus · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nasopharyngeal papillary adenocarcinoma (NPAC) is an extremely rare primary malignant tumor. There is only a limited number of cases of NPACs reported in the literature. The neoplasm presents as an exophytic mass with a papillary or polypoid appearance derived from the nasopharyngeal surface epithelium. It can potentially involve any part of the nasopharynx, but it most commonly involves the roof, the lateral, and the posterior wall. The prognosis is very good and no recurrences or metastases have been reported. Nasal obstruction is the most common manifestation. Surgical excision is considered the most appropriate treatment method. There are also reports of patients undergoing radiation therapy. However, its role in the treatment has not been clarified. The presence of this tumor in the nasal cavity could be easily underestimated, because of its appearance. As a result, an index of suspicion is necessary for a timely diagnostic and therapeutic intervention. We present a case of NPAC in a 26-year-old female treated in our hospital.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.